Meeting Report VLPNPV: Session 10: Virus-like particle and nano-particle vaccines
نویسندگان
چکیده
منابع مشابه
Meeting Report VLPNPV: Session 10: Rapid total particle quantification
Mark Rehse form ViroCyt opened his talk with the question of how many viruses are in the ocean as a way of introducing the topic of virus quantification. As it turns out, there is an estimated 100 million viruses in a milliliter of your average sea water, which—if you do the math—means that there are 1.3 £ 10 viruses in all of the Earth’s oceans. Add to this the fact that we have no idea how ma...
متن کاملPapillomavirus-like particle vaccines.
Papillomavirus-like particle (VLP)-based subunit vaccines have undergone rapid development over the past 8 years. Three types are being investigated. The most basic type is composed of only the L1 major capsid protein and is designed to prevent genital human papillomavirus (HPV) infection by inducing virus-neutralizing antibodies. On the basis of positive results in animal models, clinical tria...
متن کاملVirus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
It is acknowledged that vaccines remain the best hope for eliminating the HIV-1 epidemic. However, the failure to produce effective vaccine immunogens and the inability of conventional delivery strategies to elicit the desired immune responses remains a central theme and has ultimately led to a significant roadblock in HIV vaccine development. Consequently, significant efforts have been applied...
متن کاملVirus-like particle (VLP)-based vaccines for pandemic influenza
The influenza pandemic of 2009 demonstrated the inability of the established global capacity for egg-based vaccine production technology to provide sufficient vaccine for the population in a timely fashion. Several alternative technologies for developing influenza vaccines have been proposed, among which non-replicating virus-like particles (VLPs) represent an attractive option because of their...
متن کاملVersatile Virus-Like Particle Carrier for Epitope Based Vaccines
BACKGROUND Recombinant proteins and in particular single domains or peptides are often poorly immunogenic unless conjugated to a carrier protein. Virus-like-particles are a very efficient means to confer high immunogenicity to antigens. We report here the development of virus-like-particles (VLPs) derived from the RNA bacteriophage AP205 for epitope-based vaccines. METHODOLOGY/PRINCIPAL FINDI...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Human Vaccines & Immunotherapeutics
سال: 2014
ISSN: 2164-5515,2164-554X
DOI: 10.4161/hv.29840